Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 3—March 2023
CME ACTIVITY - Research

Clonal Expansion of Multidrug-Resistant Streptococcus dysgalactiae Subspecies equisimilis Causing Bacteremia, Japan, 2005–2021

Koh Shinohara, Kazunori Murase, Yasuhiro Tsuchido, Taro Noguchi, Satomi Yukawa, Masaki Yamamoto, Yasufumi Matsumura, Ichiro Nakagawa, and Miki NagaoComments to Author 
Author affiliation: Kyoto University Graduate School of Medicine, Kyoto, Japan

Main Article

Figure 2

Incidence (cases/10,000 admissions) of multidrug-resistant Streptococcus dysgalactiae subspecies equisimilis and group C or G Streptococcus bacteremia, Kyoto-Shiga region, Japan, 2011–2020. A) Kyoto University Hospital; B) Kyoto City Hospital; C) Japanese Red Cross Otsu Hospital; D) Shiga General Hospital; E) Kyoto Min-iren Chuo Hospital; F) Kyoto Katsura Hospital; G) total for all 6 hospitals included in the study.

Figure 2. Incidence (cases/10,000 admissions) of multidrug-resistant Streptococcus dysgalactiae subspecies equisimilis and group C or G Streptococcus bacteremia, Kyoto-Shiga region, Japan, 2011–2020. A) Kyoto University Hospital; B) Kyoto City Hospital; C) Japanese Red Cross Otsu Hospital; D) Shiga General Hospital; E) Kyoto Min-iren Chuo Hospital; F) Kyoto Katsura Hospital; G) total for all 6 hospitals included in the study.

Main Article

Page created: February 23, 2023
Page updated: February 23, 2023
Page reviewed: February 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external